All Pharma News
bitBiome and Kaken sign agreement on discovery of drugs for infectious diseases

bitBiome and Kaken sign agreement on discovery of drugs for infectious diseases
PR NEWSWIRE
29 Mar 2023
Share Share
CymaBay Announces Collaboration with Kaken to Develop Seladelpar

CymaBay Announces Collaboration with Kaken to Develop Seladelpar
GLOBENEWSWIRE
08 Jan 2023
Share Share
Spruce and Kaken Announce Partnership to DevelopTildacerfont for CAH in Japan

Spruce and Kaken Announce Partnership to DevelopTildacerfont for CAH in Japan
BUSINESSWIRE
05 Jan 2023
Share Share
Brickell Biotech Announces Initiation of a Ph1 Study of Sofpironium Bromide Gel

Brickell Biotech Announces Initiation of a Ph1 Study of Sofpironium Bromide Gel
GLOBENEWSWIRE
24 Jun 2021
Share Share
Numab Therapeutics and Kaken Form Co-Development Alliance for a Next

Numab Therapeutics and Kaken Form Co-Development Alliance for a Next
NUMAB
13 Jan 2021
Share Share
Brickell Biotech Announces Approval of Sofpironium Bromide Gel, 5% in Japan

Brickell Biotech Announces Approval of Sofpironium Bromide Gel, 5% in Japan
Vandana Singh SEEKING ALPHA
25 Sep 2020
Share Share
Brickell Biotech Announces Issuance of Matter Patent on Sofpironium Bromide

Brickell Biotech Announces Issuance of Matter Patent on Sofpironium Bromide
BIOSPACE
31 Aug 2020
Share Share
HitGen and Kaken Enter Into License Agreement

HitGen and Kaken Enter Into License Agreement
BUSINESS WIRE
10 Mar 2020
Share Share
Kaken Pharmaceutical, Submits New Drug Application for Sofpironium Bromide

Kaken Pharmaceutical, Submits New Drug Application for Sofpironium Bromide
GLOBE NEWSWIRE
10 Jan 2020
Share Share
HitGen, Kaken Pharma ink agreement to develop novel class of drugs

HitGen, Kaken Pharma ink agreement to develop novel class of drugs
PHARMABIZ
15 Apr 2019
Share Share